"Antibiotic resistance is a very big task for the government. What we have tried to do is create a deliberate process of knowledge gathering and collaboration that is never antagonistic to the government but complementary," a release quoted Hellen Gelband, Associate Director, Centre for Disease Dynamics, Economics and Policy (CDDEP) based in the US, as saying.
She was speaking at a symposium on Antibiotic Resistance: National Actions Contribute to a Global Solution at the ongoing international conference on infectious diseases here.
Talking about the efforts made in India to deal with antibiotic resistance, N K Ganguly, former head of the Indian Council of Medical Research and distinguished scientist, said "India hosted the first global forum on bacterial infections."
Representatives and experts on infectious diseases from India and abroad spoke on the occasion, the release added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
